id: https://openalex.org/W3177445623
doi: https://doi.org/10.1056/nejmoa2107454
title: CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
publication_date: '2021-06-26'
publication_year: 2021
cited_by_count: 1316
citation_percentile: 0.999982
pagerank: 2.594541753595549e-06
authorships:
- author_id: https://openalex.org/A5057365396
  display_name: Julian D. Gillmore
  orcid: https://orcid.org/0000-0001-6174-9232
  author_position: first
  institutions:
  - id: https://openalex.org/I4210109810
    display_name: Amyloidosis Foundation
    ror: https://ror.org/01pfv2y33
    country_code: US
    type: nonprofit
  - id: https://openalex.org/I2801138448
    display_name: The Royal Free Hospital
    ror: https://ror.org/01ge67z96
    country_code: GB
    type: healthcare
  - id: https://openalex.org/I45129253
    display_name: University College London
    ror: https://ror.org/02jx3x895
    country_code: GB
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - National Amyloidosis Centre, Division of Medicine, University College London,
    Royal Free Hospital
- author_id: https://openalex.org/A5110599195
  display_name: Ed Gane
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210126381
    display_name: Clinical Trials New Zealand
    ror: https://ror.org/0312ka630
    country_code: NZ
    type: facility
  - id: https://openalex.org/I154130895
    display_name: University of Auckland
    ror: https://ror.org/03b94tp07
    country_code: NZ
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - New Zealand Clinical Research
  - University of Auckland
- author_id: https://openalex.org/A5083601745
  display_name: "J\xF6rg T\xE4ubel"
  orcid: https://orcid.org/0000-0002-0010-207X
  author_position: middle
  institutions:
  - id: https://openalex.org/I165862685
    display_name: St George's, University of London
    ror: https://ror.org/040f08y74
    country_code: GB
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Richmond Pharmacology, St. George's University of London
- author_id: https://openalex.org/A5109164244
  display_name: Justin Kao
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I2801418622
    display_name: Auckland City Hospital
    ror: https://ror.org/05e8jge82
    country_code: NZ
    type: healthcare
  is_corresponding: false
  raw_affiliation_strings:
  - Department of Neurology, Auckland City Hospital
- author_id: https://openalex.org/A5050125018
  display_name: Marianna Fontana
  orcid: https://orcid.org/0000-0002-9233-9831
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210109810
    display_name: Amyloidosis Foundation
    ror: https://ror.org/01pfv2y33
    country_code: US
    type: nonprofit
  - id: https://openalex.org/I2801138448
    display_name: The Royal Free Hospital
    ror: https://ror.org/01ge67z96
    country_code: GB
    type: healthcare
  - id: https://openalex.org/I45129253
    display_name: University College London
    ror: https://ror.org/02jx3x895
    country_code: GB
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - National Amyloidosis Centre, Division of Medicine, University College London,
    Royal Free Hospital
- author_id: https://openalex.org/A5036578095
  display_name: Michael L. Maitland
  orcid: https://orcid.org/0000-0002-2476-5732
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210131291
    display_name: Intellia Therapeutics (United States)
    ror: https://ror.org/03b368668
    country_code: US
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - Intellia Therapeutics, Cambridge, MA
- author_id: https://openalex.org/A5006228299
  display_name: Jessica Seitzer
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210131291
    display_name: Intellia Therapeutics (United States)
    ror: https://ror.org/03b368668
    country_code: US
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - Intellia Therapeutics, Cambridge, MA
- author_id: https://openalex.org/A5080685676
  display_name: "Daniel J. O\u2019Connell"
  orcid: https://orcid.org/0000-0002-4742-683X
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210131291
    display_name: Intellia Therapeutics (United States)
    ror: https://ror.org/03b368668
    country_code: US
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - Intellia Therapeutics, Cambridge, MA
- author_id: https://openalex.org/A5102113001
  display_name: Kathryn Walsh
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210131291
    display_name: Intellia Therapeutics (United States)
    ror: https://ror.org/03b368668
    country_code: US
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - Intellia Therapeutics, Cambridge, MA
- author_id: https://openalex.org/A5035600368
  display_name: Kristy Wood
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210131291
    display_name: Intellia Therapeutics (United States)
    ror: https://ror.org/03b368668
    country_code: US
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - Intellia Therapeutics, Cambridge, MA
- author_id: https://openalex.org/A5013190744
  display_name: Jonathan A. Phillips
  orcid: https://orcid.org/0000-0001-7290-754X
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210131291
    display_name: Intellia Therapeutics (United States)
    ror: https://ror.org/03b368668
    country_code: US
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - Intellia Therapeutics, Cambridge, MA
- author_id: https://openalex.org/A5048689879
  display_name: Yuanxin Xu
  orcid: https://orcid.org/0000-0002-4878-1294
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210131291
    display_name: Intellia Therapeutics (United States)
    ror: https://ror.org/03b368668
    country_code: US
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - Intellia Therapeutics, Cambridge, MA
- author_id: https://openalex.org/A5051443263
  display_name: Adam Amaral
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210131291
    display_name: Intellia Therapeutics (United States)
    ror: https://ror.org/03b368668
    country_code: US
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - Intellia Therapeutics, Cambridge, MA
- author_id: https://openalex.org/A5104088626
  display_name: Adam P. Boyd
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210131291
    display_name: Intellia Therapeutics (United States)
    ror: https://ror.org/03b368668
    country_code: US
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - Intellia Therapeutics, Cambridge, MA
- author_id: https://openalex.org/A5114037251
  display_name: Jeffrey Cehelsky
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210131291
    display_name: Intellia Therapeutics (United States)
    ror: https://ror.org/03b368668
    country_code: US
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - Intellia Therapeutics, Cambridge, MA
- author_id: https://openalex.org/A5103167295
  display_name: Mark D. McKee
  orcid: https://orcid.org/0000-0003-1061-915X
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210131291
    display_name: Intellia Therapeutics (United States)
    ror: https://ror.org/03b368668
    country_code: US
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - Intellia Therapeutics, Cambridge, MA
- author_id: https://openalex.org/A5008093177
  display_name: Andrew Schiermeier
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210131291
    display_name: Intellia Therapeutics (United States)
    ror: https://ror.org/03b368668
    country_code: US
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - Intellia Therapeutics, Cambridge, MA
- author_id: https://openalex.org/A5021704245
  display_name: Olivier Harari
  orcid: https://orcid.org/0000-0001-8214-489X
  author_position: middle
  institutions:
  - id: https://openalex.org/I186523950
    display_name: Regeneron (United States)
    ror: https://ror.org/02f51rf24
    country_code: US
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Regeneron Pharmaceuticals, Tarrytown, NY
- author_id: https://openalex.org/A5001459606
  display_name: Andrew Murphy
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I186523950
    display_name: Regeneron (United States)
    ror: https://ror.org/02f51rf24
    country_code: US
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Regeneron Pharmaceuticals, Tarrytown, NY
- author_id: https://openalex.org/A5067322377
  display_name: Christos A. Kyratsous
  orcid: https://orcid.org/0000-0002-2596-2906
  author_position: middle
  institutions:
  - id: https://openalex.org/I186523950
    display_name: Regeneron (United States)
    ror: https://ror.org/02f51rf24
    country_code: US
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Regeneron Pharmaceuticals, Tarrytown, NY
- author_id: https://openalex.org/A5041036914
  display_name: Brian Zambrowicz
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I186523950
    display_name: Regeneron (United States)
    ror: https://ror.org/02f51rf24
    country_code: US
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Regeneron Pharmaceuticals, Tarrytown, NY
- author_id: https://openalex.org/A5038309405
  display_name: Randy Soltys
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I186523950
    display_name: Regeneron (United States)
    ror: https://ror.org/02f51rf24
    country_code: US
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Regeneron Pharmaceuticals, Tarrytown, NY
- author_id: https://openalex.org/A5014707733
  display_name: David E. Gutstein
  orcid: https://orcid.org/0000-0001-7776-3477
  author_position: middle
  institutions:
  - id: https://openalex.org/I186523950
    display_name: Regeneron (United States)
    ror: https://ror.org/02f51rf24
    country_code: US
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Regeneron Pharmaceuticals, Tarrytown, NY
- author_id: https://openalex.org/A5111203086
  display_name: John P. Leonard
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210131291
    display_name: Intellia Therapeutics (United States)
    ror: https://ror.org/03b368668
    country_code: US
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - Intellia Therapeutics, Cambridge, MA
- author_id: https://openalex.org/A5045900351
  display_name: "Laura Sepp\u2010Lorenzino"
  orcid: https://orcid.org/0000-0002-1901-8863
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210131291
    display_name: Intellia Therapeutics (United States)
    ror: https://ror.org/03b368668
    country_code: US
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - Intellia Therapeutics, Cambridge, MA
- author_id: https://openalex.org/A5062128184
  display_name: David Lebwohl
  orcid: https://orcid.org/0000-0002-4578-1977
  author_position: last
  institutions:
  - id: https://openalex.org/I4210131291
    display_name: Intellia Therapeutics (United States)
    ror: https://ror.org/03b368668
    country_code: US
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - Intellia Therapeutics, Cambridge, MA
referenced_works:
- https://openalex.org/W2003797386
- https://openalex.org/W2033005195
- https://openalex.org/W2033805890
- https://openalex.org/W2038935930
- https://openalex.org/W2045435533
- https://openalex.org/W2096261947
- https://openalex.org/W2115603949
- https://openalex.org/W2115862827
- https://openalex.org/W2124037827
- https://openalex.org/W2128758977
- https://openalex.org/W2130902107
- https://openalex.org/W2148373528
- https://openalex.org/W2158048479
- https://openalex.org/W2188931003
- https://openalex.org/W2199765595
- https://openalex.org/W2611134270
- https://openalex.org/W2774176529
- https://openalex.org/W2788997515
- https://openalex.org/W2791854174
- https://openalex.org/W2806820493
- https://openalex.org/W2809989268
- https://openalex.org/W2810909862
- https://openalex.org/W2888036721
- https://openalex.org/W2912435333
- https://openalex.org/W2955523092
- https://openalex.org/W2971824914
- https://openalex.org/W2992823069
- https://openalex.org/W2998881619
- https://openalex.org/W2999063362
- https://openalex.org/W3007098257
- https://openalex.org/W3024591577
- https://openalex.org/W3048467449
- https://openalex.org/W3097605950
- https://openalex.org/W3106443431
- https://openalex.org/W3139182093
primary_topic: 'Amyloidosis: Diagnosis, Treatment, Outcomes'
open_access: true
